Author

Kathy Holder

Observed names: K Holder, K. Holder

Institutions: Heart of England NHS Foundation Trust, Heartlands Hospital

Observed institutions: Heart of England NHS Foundation Trust, Heartlands Hospital

OpenAlex ID: A5043665917

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study

2001 · S Chakrabarti, KE Collingham, et al. · Bone Marrow Transplantation · 58

Allogeneic transplant outcomes are not affected by body mass index (BMI) in patients with haematological malignancies

2010 · Emmanouil Nikolousis, Sandeep Nagra, et al. · Annals of Hematology · 50

A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone

2004 · M Karanth, S Chakrabarti, et al. · Bone Marrow Transplantation · 17

Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease

2019 · Francesca A.M. Kinsella, Charlotte F. Inman, et al. · Leukemia Research · 15

Graft-versus-leukaemia effect post fludarabine, melphalan and alemtuzumab reduced intensity allogeneic stem cell transplant in HIV-infected patient with acute myeloid leukaemia

2018 · A. Kanellopoulos, M. Kaparou, et al. · Bone Marrow Transplantation · 4

Reduced‐intensity conditioning allogeneic transplantation after salvage treatment with DT ‐ PACE in myeloma patients relapsing early after autologous transplant

2017 · Kate Randall, Maria Kaparou, et al. · European Journal Of Haematology · 3

Pre-Transplantation Assessment Of Mortality (PAM) Score Is a Poor Predictor For Survival In The Highest Risk Group When Used In T Cell Depleted Myeloablative Allogeneic Transplants

2013 · Bhuvan Kishore, Daniel Wiseman, et al. · Blood · 2

Performing Bone Marrow Harvest on an Outpatient Basis: A Single Center UK Experience

2004 · Aamer Aleem, Richard Lovell, et al. · Acta Haematologica · 1

12-Month Full Donor Chimerism Is Associated with Low-Grade Acute Graft Versus Host Disease (aGVHD) and Predicts Superior Outcomes in Reduced Intensity (RIC) Alemtuzumab-Based Transplants for MDS and AML

2016 · Alex George Kanellopoulos, Shankaranarayana Paneesha, et al. · Blood

Single Centre Experience of Managing Patients with Double Hit Lymphoma

2016 · Shankaranarayana Paneesha, Iman Qureshi, et al. · Blood

Full Donor T Cell Chimerism Predicts Transplant Outcomes In High Risk AML But Not In Intermediate Risk AML After a T-Deplete Alemtuzumab Conditioned Transplant

2013 · Amy Gudger, Vidhya Murthy, et al. · Blood

Is Daily Lenograstim From Day +7 Of Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Is As Effective As Pegfilgrastim In Patients With Myeloma?

2013 · Ben Bailiff, Neil Phillips, et al. · Blood

Autologous Stem Cell Transplant Has a Role In Consolidating Chemotherapy Given At First Disease Progression In Multiple Myeloma Treated Exclusively With Novel Agents

2013 · Bhuvan Kishore, Shankaranarayana Paneesha, et al. · Blood

Pegfilgrastim Use in Patients with Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Is Associated with Early Neutrophil Engraftment and Shorter Inpatient Stay.

2009 · Neil Phillips, Anand Lokare, et al. · Blood

Transplant Outcome Is Not Affected by Body Mass Index (BMI) in Patients with Haematological Malignancies.

2007 · Emmanouil Nikolousis, Shankaranarayana Paneesha, et al. · Blood

Author Index Vol. 112, 2004

2004 · Chuwa Tei, Kosei Arimura, et al. · Acta Haematologica

Works count: 16

Citation count: 150

H-index: 4

I10-index: 4